Should John send the ROL his Nobel shortlist next year?
How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison?
We discuss all that and more on this week's episode of "The Readout LOUD," STAT's biotech podcast. First, biotech veteran John Maraganore calls in to discuss his new startup, City Therapeutics, this week's Nobel Prize awards, and the nerdy accolade he just received. We also talk to STAT's Megan Molteni about her new article on "CRISPR baby" scientist He Jiankui and his new cryptocurrency financier. Listen Now For more on why a crypto bro would get involved in CRISPR, go here; to read about City Therapeutics, go here; to learn more about the Nobel Prize-winning work in AI protein design, go here; and you can purchase tickets for the STAT Summit in Boston here (listen to the beginning of the episode for a great discount code). Subscribe to the podcast to never miss an episode Visit the archive to see past episodes |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments